Gotu Kola

Gotu Kola (Centella asiatica) contains triterpenoid saponins (asiaticoside, madecassoside, asiatic acid, and madecassic acid) that enhance cognitive function by increasing BDNF levels and protecting neurons from oxidative damage, while also promoting wound healing and vascular health through stimulating collagen synthesis and reducing inflammation, with clinical evidence supporting its benefits for memory, attention, and venous insufficiency at 300-600mg daily of standardized extract (40% triterpenes), though it should be avoided during pregnancy and by those with liver disease.

Alternative Names: Centella asiatica, Indian Pennywort, Brahmi, Mandookaparni, Asiatic Pennywort, Tiger Herb, Hydrocotyle asiatica

Categories: Adaptogen, Nootropic, Medicinal Herb, Ayurvedic Herb

Primary Longevity Benefits


  • Cognitive enhancement
  • Neuroprotection
  • Wound healing
  • Vascular health

Secondary Benefits


  • Anxiety reduction
  • Stress management
  • Skin health
  • Anti-inflammatory
  • Antioxidant support
  • Collagen production

Mechanism of Action


Gotu Kola (Centella asiatica) exerts its diverse therapeutic effects through multiple mechanisms, primarily attributed to its bioactive compounds, especially the triterpenoid saponins (asiaticoside, madecassoside, asiatic acid, and madecassic acid) and other constituents including flavonoids, phytosterols, and phenolic compounds. In the central nervous system, Gotu Kola demonstrates neuroprotective properties by modulating several pathways. It enhances antioxidant defense mechanisms by increasing the activities of superoxide dismutase (SOD), catalase, and glutathione peroxidase, thereby reducing oxidative stress and preventing neuronal damage. Research indicates that Gotu Kola’s triterpenoids can cross the blood-brain barrier and protect neurons from beta-amyloid toxicity, a key factor in Alzheimer’s disease pathology.

Additionally, it promotes neurogenesis and synaptogenesis by increasing brain-derived neurotrophic factor (BDNF) levels, which supports the growth and differentiation of neurons and enhances synaptic plasticity. Gotu Kola also modulates neurotransmitter systems, particularly by influencing gamma-aminobutyric acid (GABA) activity, which contributes to its anxiolytic and stress-reducing effects. For vascular health, Gotu Kola strengthens blood vessel walls by stimulating the production of type I collagen in the vascular wall and improving microcirculation. It enhances venous tone and decreases capillary permeability, which explains its efficacy in treating venous insufficiency and reducing edema.

The herb also inhibits platelet aggregation and improves blood flow through its mild vasodilatory effects. In wound healing and skin health, Gotu Kola’s triterpenoids stimulate fibroblast proliferation and increase collagen synthesis, particularly type I collagen, which is essential for wound repair and tissue regeneration. It enhances the tensile strength of newly formed skin and accelerates epithelialization. The herb also exhibits significant anti-inflammatory properties by inhibiting pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and by suppressing the activity of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS).

This anti-inflammatory action is complemented by its ability to modulate the NF-κB signaling pathway, a key regulator of inflammatory responses. Gotu Kola’s antioxidant effects extend beyond the nervous system, as it scavenges free radicals throughout the body and reduces lipid peroxidation in various tissues. It also enhances cellular antioxidant capacity by increasing the levels of endogenous antioxidants like glutathione. At the molecular level, Gotu Kola influences several signaling pathways involved in cell proliferation, differentiation, and survival.

It modulates the mitogen-activated protein kinase (MAPK) pathway, which regulates cellular responses to various stimuli, and affects the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway, which plays a crucial role in cell survival and metabolism. Recent research suggests that Gotu Kola may also influence epigenetic mechanisms by modulating DNA methylation patterns and histone modifications, potentially explaining its long-term effects on gene expression and cellular function. Additionally, it has been shown to enhance mitochondrial function and biogenesis, improving cellular energy production and reducing oxidative stress generated by mitochondrial dysfunction. In the immune system, Gotu Kola exhibits immunomodulatory effects by balancing pro-inflammatory and anti-inflammatory responses, enhancing macrophage phagocytic activity, and modulating T-cell function.

This balanced approach to immune regulation contributes to its therapeutic potential in various inflammatory and immune-related conditions.

Optimal Dosage


Disclaimer: The following dosage information is for educational purposes only. Always consult with a healthcare provider before starting any supplement regimen, especially if you have pre-existing health conditions, are pregnant or nursing, or are taking medications.

Dosage of Gotu Kola varies based on the form used and the condition being treated. For standardized extracts (typically standardized to contain 40% asiaticoside, 29-30% asiatic acid, 29-30% madecassic acid, and 1-2% madecassoside), the typical dosage range is 60-180 mg daily, divided into 2-3 doses. For crude herb or dried leaf preparations, 500-1000 mg three times daily is commonly recommended.

By Condition

Condition Dosage Notes
Cognitive enhancement and neuroprotection 300-600 mg of standardized extract (containing at least 40% total triterpenes) daily, divided into 2-3 doses Effects may take 4-6 weeks to become noticeable; higher doses within this range may be more effective for age-related cognitive decline
Anxiety and stress management 500 mg of dried herb or 60-120 mg of standardized extract twice daily May be combined with other anxiolytic herbs like Bacopa monnieri or Ashwagandha for enhanced effects
Venous insufficiency and edema 60-120 mg of standardized extract (TTFCA – Total Triterpenoid Fraction of Centella Asiatica) daily Clinical studies have shown significant improvement in venous insufficiency symptoms after 2-4 weeks of consistent use
Wound healing and scar prevention Topical application of creams/ointments containing 1% Gotu Kola extract, applied 2-3 times daily; or 60-120 mg oral standardized extract daily Combined topical and oral administration may provide enhanced benefits for severe wounds or scars
Skin conditions (psoriasis, eczema) Topical application of 0.5-1% extract twice daily; or 60-120 mg oral standardized extract daily Consistent application for at least 4-8 weeks is recommended for noticeable improvement

By Age Group

Age Group Dosage Notes
Adults (18-65 years) 300-600 mg standardized extract or 500-1000 mg dried herb daily Generally well-tolerated; start at lower doses and gradually increase as needed
Elderly (65+ years) 250-500 mg standardized extract daily, starting with lower doses May be particularly beneficial for age-related cognitive decline and vascular issues; monitor for potential interactions with medications
Children (under 18 years) Not recommended without medical supervision Limited safety data in pediatric populations; consult healthcare provider before use

By Form

Form Dosage Notes
Standardized extract (40% asiaticoside) 60-180 mg daily, divided into 2-3 doses Most consistent potency and research support; preferred for therapeutic applications
Dried herb/leaf powder 500-1000 mg, 2-3 times daily Contains the full spectrum of compounds but variable potency; may require higher doses for therapeutic effects
Tincture (1:5 ratio) 2-4 mL, 2-3 times daily Rapid absorption; alcohol content may be a consideration for some individuals
Tea 1-2 teaspoons (2-4 g) of dried herb steeped in hot water for 10-15 minutes, consumed 2-3 times daily Lower potency than extracts; pleasant way to consume but may require consistent, long-term use for therapeutic effects
Topical preparations Creams/ointments containing 0.5-1% extract, applied 2-3 times daily to affected areas Particularly effective for wound healing, scar prevention, and skin conditions

Timing Recommendations

For optimal absorption and effectiveness, Gotu Kola is best taken with meals to minimize potential gastrointestinal discomfort. When used for cognitive enhancement, morning and early afternoon dosing is recommended to potentially enhance daytime cognitive function without interfering with sleep. For anxiety and stress management, doses can be timed to coincide with periods of anticipated stress or taken regularly throughout the day for general anxiety reduction.

Cycling Recommendations

While there is no strong evidence suggesting tolerance development with Gotu Kola, some practitioners recommend cycling the herb (e.g., 8-12 weeks on, 2-4 weeks off) for long-term use to potentially enhance effectiveness and minimize any unforeseen adverse effects from continuous use. However, for conditions like venous insufficiency or wound healing, continuous use may be more appropriate until the desired therapeutic outcome is achieved.

Special Considerations

Standardized extracts are generally preferred for therapeutic applications due to their consistent potency and better research support. The triterpenoid content (asiaticoside, madecassoside, asiatic acid, and madecassic acid) is considered the primary marker for potency and efficacy.

When selecting a supplement, look for products standardized to contain at least 40% total triterpenes or 10% asiaticoside. For enhanced absorption, taking Gotu Kola with a small amount of healthy fat may be beneficial, as some of its active compounds are fat-soluble.

Bioavailability


Absorption Rate

The bioavailability of Gotu Kola’s active compounds varies significantly based on the specific triterpenoids and the formulation used. In general, the triterpene glycosides (asiaticoside and madecassoside) have relatively poor oral bioavailability (estimated at 20-30%) due to their large molecular size and hydrophilic nature, which limits passive diffusion across intestinal membranes. The free triterpene acids (asiatic acid and madecassic acid) show somewhat better absorption profiles (30-50% bioavailability) due to their more lipophilic nature.

Pharmacokinetics

Absorption: Absorption primarily occurs in the small intestine. The triterpene glycosides may undergo partial hydrolysis by intestinal beta-glucosidases to release their aglycones (asiatic acid and madecassic acid), which are then absorbed. Some absorption may also occur through active transport mechanisms.

Distribution: Once absorbed, the triterpenoids are distributed throughout the body, with evidence suggesting they can cross the blood-brain barrier, particularly the more lipophilic asiatic acid and madecassic acid. This explains their neurological and cognitive effects.

Metabolism: The triterpenoids undergo hepatic metabolism, primarily through phase I (oxidation, reduction, hydrolysis) and phase II (conjugation) reactions. Asiaticoside is metabolized to asiatic acid in the liver and intestine, while both asiatic acid and madecassic acid undergo glucuronidation and sulfation.

Elimination: The metabolites are primarily excreted through the kidneys in urine, with a smaller portion eliminated via biliary excretion in feces. The elimination half-life of the major triterpenoids ranges from 2.2-6.6 hours.

Onset Of Action: Acute effects may be noticed within 1-3 hours after ingestion, though many of the therapeutic benefits require consistent use over weeks to months.

Peak Plasma Concentration: Typically reached within 1.5-2.5 hours after oral administration for the free triterpene acids, and 2-4 hours for the glycosides.

Enhancement Methods

Method Description Effectiveness
Standardized extracts Extracts standardized to contain higher concentrations of triterpenoids provide more consistent and potent effects compared to crude herb preparations. Significantly improves therapeutic potential by ensuring consistent delivery of active compounds.
Fat co-administration Taking Gotu Kola with a meal containing healthy fats or oils may enhance the absorption of the more lipophilic compounds (asiatic acid and madecassic acid). May increase bioavailability by 15-30% for the triterpene acids.
Piperine co-administration Black pepper extract (piperine) inhibits certain drug-metabolizing enzymes and P-glycoprotein efflux pumps, potentially enhancing the bioavailability of Gotu Kola’s active compounds. Studies with similar herbal compounds suggest potential bioavailability enhancement of 30-50%, though specific data for Gotu Kola is limited.
Water-soluble formulations Newer formulations like Centell-S have been developed with enhanced water solubility compared to traditional extracts. May significantly improve bioavailability, particularly of the glycosidic compounds, with some studies showing 2-3 fold increases in plasma concentrations.
Liposomal delivery Encapsulation of Gotu Kola extracts in phospholipid liposomes can enhance absorption by facilitating transport across intestinal membranes. Emerging research suggests potential bioavailability improvements of 2-4 fold, though commercial liposomal Gotu Kola products are still limited.
Micronization Reducing particle size through micronization increases the surface area available for dissolution and absorption. May improve dissolution rate and subsequent absorption by 20-40%, particularly for the less water-soluble compounds.

Factors Affecting Absorption

Factor Impact
Gastrointestinal pH The slightly acidic environment of the stomach may enhance the solubility of certain triterpenoids, while the more alkaline intestinal environment may facilitate the absorption of others. Conditions that significantly alter GI pH may affect overall absorption.
Food intake Taking Gotu Kola with meals, particularly those containing fats, may enhance the absorption of lipophilic compounds but might slightly delay peak plasma concentrations.
Intestinal microbiota Gut bacteria may play a role in hydrolyzing the glycosides to their aglycones, potentially enhancing absorption. Variations in gut microbiota composition may contribute to individual differences in response.
Age Older adults may experience reduced absorption due to age-related changes in gastrointestinal function, potentially requiring adjusted dosing strategies.
Concurrent medications Drugs that alter gastric emptying, intestinal motility, or pH may affect the absorption of Gotu Kola’s active compounds. Additionally, medications that compete for the same metabolic enzymes may influence bioavailability.

Timing Recommendations

For optimal absorption, Gotu Kola supplements are best taken with meals, particularly those containing some healthy fats. Dividing the daily dose into 2-3 administrations throughout the day may help maintain more consistent blood levels of the active compounds, given their relatively short half-lives. For cognitive enhancement, morning and early afternoon dosing is often recommended to align with daily cognitive demands.

Research Gaps

Despite its long history of use, detailed pharmacokinetic studies of Gotu Kola in humans are limited. More research is needed to fully characterize the absorption, distribution, metabolism, and excretion profiles of its various bioactive compounds, particularly in different populations and

when used in combination with other supplements or medications.

Additionally , the potential role of the gut microbiome in modulating the bioavailability of Gotu Kola’s active compounds warrants further investigation.

Safety Profile


Safety Rating i

4High Safety

General Safety Assessment

Gotu Kola has a generally favorable safety profile when used at recommended dosages for short to medium-term periods (up to 6 months). It has been used traditionally for centuries with few reported serious adverse effects. Most clinical trials report good tolerability with mild, transient side effects. However, long-term safety data beyond 6-12 months is limited, and certain populations should exercise caution or avoid use.

Side Effects

Common:

Effect Incidence Management
Gastrointestinal discomfort 5-15% of users Taking with food may reduce symptoms; dividing daily dose into smaller, more frequent doses may help
Nausea 3-10% of users Taking with food; starting with lower doses and gradually increasing
Drowsiness 2-8% of users Adjusting timing of doses; avoiding concurrent use with other sedatives
Headache 2-5% of users Usually transient; ensuring adequate hydration may help

Uncommon:

Effect Incidence Management
Skin rash or itching 1-3% of users Discontinue use and consult healthcare provider; may indicate allergic reaction
Dizziness 1-3% of users Taking while seated; avoiding sudden position changes; reducing dosage
Dry mouth 1-2% of users Staying well-hydrated; using sugar-free lozenges or gum

Rare:

Effect Incidence Management
Elevated liver enzymes <1% of users Discontinue use and seek medical evaluation; monitor liver function in those with pre-existing liver conditions
Photosensitivity <0.5% of users Use sun protection; discontinue if severe reactions occur
Allergic reactions (severe) <0.1% of users Seek immediate medical attention; discontinue use permanently

Contraindications

Condition Rationale
Pregnancy and breastfeeding Insufficient safety data; some animal studies suggest potential effects on fetal development; traditionally considered contraindicated in pregnancy
Pre-existing liver disease Rare reports of hepatotoxicity; may potentially exacerbate existing liver conditions
Scheduled surgery May increase risk of sedation with anesthetics and potentially affect blood glucose levels; discontinue at least 2 weeks before scheduled surgery
History of skin cancer or pre-cancerous skin lesions Theoretical concern based on its effects on cell proliferation; insufficient evidence to establish safety
Children under 12 years Limited safety data in pediatric populations; benefits may not outweigh potential risks

Drug Interactions

Drug Class Examples Interaction Type Severity Management
Sedatives and CNS depressants Array Additive sedation Moderate Avoid concurrent use or use with caution; monitor for excessive sedation
Hepatotoxic medications Array Potential additive hepatotoxicity Moderate to severe Avoid concurrent use; monitor liver function if combination cannot be avoided
Anticoagulants and antiplatelet drugs Array Potential increased bleeding risk Moderate Monitor for signs of bleeding; consider more frequent INR monitoring with warfarin
Antidiabetic medications Array Potential additive hypoglycemic effects Mild to moderate Monitor blood glucose levels; dosage adjustments of diabetes medications may be necessary
Diuretics Array Potential additive diuretic effect Mild Monitor for signs of dehydration or electrolyte imbalances

Upper Limit

Most clinical studies have used doses up to 600 mg of standardized extract daily without significant adverse effects. Doses exceeding 1000 mg of standardized extract daily have not been well-studied and may increase the risk of side effects without providing additional benefits. For crude herb preparations, doses above 3000 mg daily are not recommended.

Long Term Safety

Safety data for continuous use beyond 6-12 months is limited. While no specific cumulative toxicity has been identified, periodic breaks from supplementation (e.g., 1-2 weeks off after every 3-4 months of use) may be prudent for those using Gotu Kola long-term. Regular monitoring of liver function is advisable for extended use.

Special Populations

Elderly: Generally well-tolerated, but start with lower doses (50-75% of standard adult dose) and monitor for increased sensitivity to sedative effects or interactions with medications commonly used in this population

Liver Impairment: Use with caution; start with reduced doses (50% of standard dose) and monitor liver function; avoid in severe liver disease

Kidney Impairment: Limited data; use with caution in moderate to severe renal impairment; consider reduced dosing

Autoimmune Conditions: Theoretical concern due to immunomodulatory effects; insufficient evidence to establish safety; use with caution and medical supervision

Allergic Potential

Gotu Kola belongs to the Apiaceae (Umbelliferae) family, which includes carrots, celery, and parsley. Individuals with known allergies to plants in this family may have an increased risk of allergic reactions to Gotu Kola and should exercise caution.

Toxicology

Acute Toxicity: Animal studies show low acute toxicity with LD50 values >2000 mg/kg body weight for extracts

Subchronic Toxicity: 90-day studies in rodents show no significant adverse effects at doses equivalent to 5-10 times the human therapeutic dose

Genotoxicity: Standard genotoxicity assays (Ames test, chromosomal aberration) have generally been negative at therapeutic concentrations

Carcinogenicity: Limited long-term studies; no evidence of carcinogenic potential in available research, but comprehensive carcinogenicity testing is lacking

Reproductive Toxicity: Some animal studies suggest potential effects on fetal development; avoid during pregnancy until more safety data is available

Overdose Information

Limited reports of significant overdose exist. Theoretical symptoms might include severe gastrointestinal distress, excessive sedation, dizziness, confusion, and potentially liver stress. Treatment would be supportive, including gastric decontamination if recently ingested, and monitoring of liver function. No specific antidote is known.

Safety Monitoring Recommendations

For long-term use (>3 months), periodic monitoring of liver function (every 3-6 months) is advisable. Those with pre-existing medical conditions or taking multiple medications should consult healthcare providers before use and undergo appropriate monitoring based on individual risk factors.

Regulatory Status


Fda Status

Classification: Dietary Supplement

Approval Status: Not FDA-approved as a drug

Regulatory Framework: Regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994

Marketing Restrictions: Cannot be marketed with claims to treat, cure, or prevent any disease

Gras Status: Not generally recognized as safe (GRAS) for use in conventional foods

Safety Notifications: No significant FDA safety alerts or mandatory recalls specifically for Gotu Kola as of 2024

Notes: While available as a supplement, manufacturers are responsible for ensuring safety before marketing; FDA can take action against unsafe products after they reach the market

International Status

Eu

Classification: Traditional Herbal Medicinal Product (THMP) in some countries; food supplement in others
Regulatory Framework: Regulated under the Traditional Herbal Medicinal Products Directive (2004/24/EC) when marketed as medicine
Approved Indications: When registered as THMP, may be indicated for minor venous insufficiency and wound healing based on traditional use
Notable Countries:
  • Approved in Commission E Monographs for wound healing and venous insufficiency
  • Registered medicinal products available for venous conditions
  • Available both as registered medicine and food supplement
  • Available primarily as food supplement; some traditional herbal registrations
Notes: European Medicines Agency (EMA) has published a community herbal monograph for Centella asiatica

Canada

  • Natural Health Product (NHP)
  • Regulated under the Natural Health Products Regulations
  • Several licensed products with Natural Product Numbers (NPNs)
  • Licensed products may claim to help support peripheral circulation and wound healing when specific quality and safety requirements are met
  • Health Canada has published a monograph for Gotu Kola providing guidance on acceptable claims, dosage, and safety information

Australia

  • Listed medicine on the Australian Register of Therapeutic Goods (ARTG)
  • Regulated by the Therapeutic Goods Administration (TGA)
  • May be marketed with low-level claims related to traditional use in herbal medicine
  • Must comply with quality and safety standards; evidence for efficacy based on traditional use is acceptable for listed medicines

India

  • Ayurvedic medicine; also available as food supplement
  • Regulated under the Drugs and Cosmetics Act, 1940 and Rules 1945 as amended for Ayurvedic medicines
  • Recognized in official Ayurvedic pharmacopoeias and formularies
  • Widely used in traditional medicine with extensive historical documentation supporting its use

China

  • Traditional Chinese Medicine (TCM)
  • Regulated by the National Medical Products Administration (NMPA)
  • Listed in the Chinese Pharmacopoeia
  • Long history of documented use in TCM; subject to quality control standards specified in the pharmacopoeia

Japan

  • Non-prescription quasi-drug or dietary supplement depending on formulation and claims
  • Regulated by the Ministry of Health, Labour and Welfare
  • Stricter regulation than many countries for health claims on supplements

Clinical Guidelines

Inclusion In Treatment Protocols

  • Some European clinical guidelines mention standardized Centella asiatica extracts as an option for chronic venous insufficiency
  • Limited inclusion in wound care protocols, primarily in integrative medicine settings
  • Not typically included in mainstream clinical guidelines for cognitive conditions, though mentioned in some integrative medicine protocols

Professional Organization Positions

  • Recognized as safe when used appropriately; included in Botanical Safety Handbook
  • Monograph supports use for venous insufficiency and wound healing
  • Included in WHO monographs on selected medicinal plants

Import Regulations

Personal Use: Generally permitted for personal use in most countries in limited quantities (typically 1-3 months supply)

Commercial Import: Subject to dietary supplement or herbal medicine import regulations depending on the country

Customs Considerations: May be subject to inspection; documentation of identity and purity may be required for larger quantities

Quality Standards

Pharmacopoeial Monographs

  • No official monograph, but quality standards available through USP Dietary Supplement Verification Program
  • Official monograph establishing quality standards for medicinal use
  • Detailed monograph with quality specifications
  • Official monograph with quality standards for TCM use

Industry Standards

  • Detailed monograph with botanical identification, analytical methods, and quality control parameters
  • Methods for analysis of triterpenoid content

Legal Status For Sports

Wada Status: Not on the World Anti-Doping Agency Prohibited List

Testing: Not typically included in standard anti-doping screening protocols

Sports Organization Policies: No major sports organizations specifically prohibit Gotu Kola use

Notes: Athletes should exercise caution with all supplements due to potential contamination risks

Future Regulatory Trends

Potential Changes: Increasing standardization of quality requirements globally; potential for more specific health claims in some jurisdictions based on growing clinical evidence

Research Impact: Ongoing clinical research may support expanded approved indications in countries with traditional herbal medicine registration pathways

Harmonization Efforts: International initiatives to harmonize herbal medicine regulations may affect Gotu Kola’s regulatory status across borders

Labeling Requirements

Usa: Must be labeled as dietary supplement; cannot make disease claims; structure/function claims must be accompanied by FDA disclaimer

Eu: When sold as food supplement, must comply with Food Supplements Directive labeling requirements; as THMP, requires approved product information

Canada: Must display Natural Product Number (NPN), medicinal and non-medicinal ingredients, recommended use, cautions, and warnings

Common Warnings: Pregnancy/breastfeeding warning; potential medication interaction warning; discontinue before surgery warning

Synergistic Compounds


Compound: Bacopa monnieri (Brahmi)
Synergy Mechanism: Both herbs support cognitive function through complementary mechanisms. While Gotu Kola enhances cerebral blood flow, reduces oxidative stress, and promotes neurogenesis, Bacopa primarily works through enhancing synaptic communication, modulating neurotransmitters, and protecting neurons from damage. Together, they provide comprehensive support for cognitive function and neuroprotection.
Evidence Rating: 3
Recommended Combination: 250-500 mg of standardized Gotu Kola extract with 300-600 mg of standardized Bacopa extract (containing at least 50% bacosides) daily
Research Notes: Traditional Ayurvedic combinations; several animal studies support synergistic cognitive enhancement; limited human clinical trials on the combination

Compound: Ginkgo biloba
Synergy Mechanism: Ginkgo enhances cerebral blood flow and has potent antioxidant properties, complementing Gotu Kola’s neuroprotective and cognitive-enhancing effects. Ginkgo also inhibits platelet-activating factor, while Gotu Kola strengthens vascular walls, potentially providing comprehensive vascular support.
Evidence Rating: 3
Recommended Combination: 250-500 mg of Gotu Kola extract with 120-240 mg of standardized Ginkgo extract (containing 24% flavone glycosides and 6% terpene lactones) daily
Research Notes: Theoretical synergy based on complementary mechanisms; some clinical evidence for each herb individually for cognitive enhancement; limited research on the combination

Compound: Piperine (Black Pepper Extract)
Synergy Mechanism: Piperine enhances the bioavailability of Gotu Kola’s active triterpenoids by inhibiting certain drug-metabolizing enzymes (particularly CYP3A4) and P-glycoprotein efflux pumps in the intestinal wall. This allows more of the active compounds to enter systemic circulation.
Evidence Rating: 2
Recommended Combination: 500 mg of Gotu Kola extract with 5-10 mg of piperine
Research Notes: Demonstrated bioavailability enhancement for various herbal compounds; specific research with Gotu Kola is limited but mechanistically sound

Compound: Vitamin E
Synergy Mechanism: Vitamin E is a potent lipid-soluble antioxidant that complements Gotu Kola’s water-soluble antioxidant compounds. Together, they provide more comprehensive protection against oxidative stress in both aqueous and lipid cellular compartments, potentially enhancing neuroprotective effects.
Evidence Rating: 2
Recommended Combination: 300-500 mg of Gotu Kola extract with 200-400 IU of mixed tocopherols (Vitamin E)
Research Notes: Theoretical synergy based on complementary antioxidant mechanisms; limited specific research on the combination

Compound: Collagen peptides
Synergy Mechanism: Gotu Kola stimulates collagen synthesis and fibroblast proliferation, while collagen peptides provide the building blocks for new collagen formation. This combination may enhance skin health, wound healing, and connective tissue repair beyond what either could achieve alone.
Evidence Rating: 2
Recommended Combination: 250-500 mg of Gotu Kola extract with 5-10 g of hydrolyzed collagen peptides daily
Research Notes: Emerging research in dermatology and wound care; mechanistically sound but limited clinical studies on the combination

Compound: Horse Chestnut Extract (Aesculus hippocastanum)
Synergy Mechanism: For venous conditions, Horse Chestnut’s active compound aescin strengthens vein walls and improves venous tone, while Gotu Kola’s triterpenoids enhance microcirculation, reduce capillary permeability, and promote connective tissue healing. Together, they address multiple aspects of venous insufficiency.
Evidence Rating: 3
Recommended Combination: 60-120 mg of standardized Gotu Kola extract (TTFCA) with 300-600 mg of Horse Chestnut extract (standardized to 50-75 mg aescin) daily
Research Notes: Both herbs have clinical evidence for venous insufficiency individually; some European formulations combine them; limited research on the specific combination

Compound: Lion’s Mane Mushroom (Hericium erinaceus)
Synergy Mechanism: Lion’s Mane stimulates nerve growth factor (NGF) production and supports nerve regeneration, while Gotu Kola enhances cerebral circulation, reduces oxidative stress, and promotes neurogenesis. Together, they may provide comprehensive support for neurological health and cognitive function.
Evidence Rating: 2
Recommended Combination: 300-500 mg of Gotu Kola extract with 500-1000 mg of Lion’s Mane extract daily
Research Notes: Emerging combination in nootropic formulations; theoretical synergy based on complementary mechanisms; limited specific research

Compound: Ashwagandha (Withania somnifera)
Synergy Mechanism: Ashwagandha’s adaptogenic and stress-reducing properties complement Gotu Kola’s cognitive-enhancing and anxiolytic effects. Ashwagandha primarily works through modulating the HPA axis and cortisol levels, while Gotu Kola enhances cerebral circulation and GABA activity, potentially providing more comprehensive stress management and cognitive support.
Evidence Rating: 2
Recommended Combination: 300-500 mg of Gotu Kola extract with 300-600 mg of Ashwagandha extract (standardized to 5% withanolides) daily
Research Notes: Traditional Ayurvedic combination; limited modern research on the specific combination

Compound: Grape Seed Extract
Synergy Mechanism: Grape Seed Extract contains proanthocyanidins with potent antioxidant and vascular-protective properties that complement Gotu Kola’s effects on microcirculation and vascular integrity. Together, they may provide enhanced protection against vascular damage and improved microcirculation.
Evidence Rating: 2
Recommended Combination: 250-500 mg of Gotu Kola extract with 100-300 mg of Grape Seed Extract (standardized to 95% proanthocyanidins) daily
Research Notes: Theoretical synergy based on complementary vascular mechanisms; limited specific research on the combination

Antagonistic Compounds


Compound: Hepatotoxic medications and herbs
Interaction Type: Potential additive hepatotoxicity
Evidence Rating: 2
Mechanism: While rare, Gotu Kola has been associated with isolated cases of hepatotoxicity. Concurrent use with other substances that can affect liver function may increase the risk of liver damage through additive or synergistic hepatotoxic effects.
Examples:
Acetaminophen (high doses), Kava kava, Comfrey, Certain statins, Methotrexate, Isoniazid
Management: Avoid concurrent use when possible; if unavoidable, monitor liver function regularly; discontinue at first sign of liver dysfunction (elevated enzymes, jaundice, abdominal pain)

Compound: Sedative medications and herbs
Interaction Type: Additive sedation
Evidence Rating: 2
Mechanism: Gotu Kola may have mild sedative properties through its effects on GABA neurotransmission. When combined with other sedatives, it may enhance CNS depression, potentially leading to excessive sedation or impaired psychomotor function.
Examples:
Benzodiazepines, Barbiturates, Opioids, Valerian, Kava kava, Passionflower, Alcohol
Management: Avoid concurrent use or use with caution; reduce dosages of sedative medications if combination cannot be avoided; avoid activities requiring alertness until individual response is known

Compound: Anticoagulant and antiplatelet medications
Interaction Type: Potential increased bleeding risk
Evidence Rating: 2
Mechanism: Some research suggests Gotu Kola may have mild anticoagulant and antiplatelet effects. When combined with medications that affect blood clotting, it could theoretically increase the risk of bleeding through additive effects on different aspects of hemostasis.
Examples:
Warfarin, Heparin, Aspirin, Clopidogrel, NSAIDs, Fish oil (high doses), Ginkgo biloba
Management: Use with caution; monitor for signs of increased bleeding (bruising, prolonged bleeding time); consider more frequent INR monitoring if taking warfarin; discontinue 2 weeks before scheduled surgery

Compound: Antidiabetic medications
Interaction Type: Potential hypoglycemic effects
Evidence Rating: 1
Mechanism: Some animal studies suggest Gotu Kola may have hypoglycemic effects. When combined with antidiabetic medications, it could potentially enhance blood glucose lowering, leading to hypoglycemia in susceptible individuals.
Examples:
Insulin, Sulfonylureas, Metformin, Thiazolidinediones, GLP-1 agonists
Management: Monitor blood glucose levels more frequently when starting or stopping Gotu Kola; be alert for signs of hypoglycemia; dosage adjustments of diabetes medications may be necessary

Compound: Immunosuppressant medications
Interaction Type: Potential interference with immunosuppression
Evidence Rating: 1
Mechanism: Gotu Kola has demonstrated immunomodulatory effects in some studies. Theoretically, it could interfere with the action of immunosuppressant medications, potentially reducing their effectiveness in preventing organ rejection or controlling autoimmune conditions.
Examples:
Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate, Corticosteroids
Management: Avoid concurrent use in transplant recipients or those with severe autoimmune conditions requiring immunosuppression; if use is considered, close monitoring of disease activity and drug levels (where applicable) is essential

Compound: Anticholinergic medications
Interaction Type: Potential reduction of therapeutic effects
Evidence Rating: 1
Mechanism: Some research suggests Gotu Kola may have mild cholinergic effects. Theoretically, it could oppose the action of anticholinergic medications, potentially reducing their effectiveness for conditions like overactive bladder or certain movement disorders.
Examples:
Atropine, Scopolamine, Oxybutynin, Tolterodine, Some antihistamines, Some antipsychotics
Management: Monitor for reduced effectiveness of anticholinergic medications; dosage adjustments may be necessary; consider alternative herbs without cholinergic properties if anticholinergic therapy is essential

Compound: Diuretic medications
Interaction Type: Potential additive diuretic effects
Evidence Rating: 1
Mechanism: Traditional use and some research suggest Gotu Kola may have mild diuretic properties. When combined with pharmaceutical diuretics, it could potentially enhance fluid and electrolyte loss, increasing the risk of dehydration or electrolyte imbalances.
Examples:
Hydrochlorothiazide, Furosemide, Spironolactone, Bumetanide
Management: Ensure adequate hydration; monitor for signs of excessive diuresis (dizziness, thirst, dry mouth); consider electrolyte monitoring, particularly potassium, in vulnerable individuals

Compound: Cytochrome P450 substrate medications
Interaction Type: Potential pharmacokinetic interactions
Evidence Rating: 1
Mechanism: Limited in vitro research suggests Gotu Kola may affect certain cytochrome P450 enzymes, particularly CYP2C9 and CYP3A4. This could theoretically alter the metabolism of medications that are substrates for these enzymes, potentially affecting their blood levels and efficacy or toxicity.
Examples:
Warfarin (CYP2C9), Many statins (CYP3A4), Certain antiepileptics, Some antidepressants, Several calcium channel blockers
Management: Use with caution; monitor for unexpected changes in drug effects or side effects; consider therapeutic drug monitoring where available for medications with narrow therapeutic indices

Cost Efficiency


Relative Cost

Low to Medium

Cost Per Effective Dose

Daily Cost Range: $0.10 – $1.50 for typical effective dose (300-600 mg standardized extract or 500-1000 mg dried herb)

Monthly Cost Range: $3 – $45 for continuous use

Annual Cost Range: $36 – $540 for continuous use

Notes: Costs vary significantly based on form, standardization level, brand reputation, and purchase volume. Bulk herbs and non-standardized preparations are typically at the lower end of the range, while highly standardized extracts and premium brands are at the higher end.

Price Comparison By Form

Form Typical Price Range Cost Per Effective Dose Notes
Dried herb (bulk) $15 – $30 per pound (454 g) $0.10 – $0.20 for 3-6 g daily dose Most economical option but requires preparation (tea) or encapsulation; potency and quality can be highly variable
Powdered herb (capsules) $8 – $20 for 60-100 capsules (500 mg each) $0.25 – $0.65 for 1000 mg daily dose Convenient but still variable in potency; moderate cost option
Standardized extract (capsules) $15 – $35 for 60 capsules (300-500 mg each) $0.50 – $1.20 for 300-600 mg daily dose Higher cost but more consistent potency and potentially greater efficacy; preferred for therapeutic applications
Tincture (1:5 ratio) $12 – $25 for 1-2 oz (30-60 ml) $0.40 – $0.85 for 2-4 ml daily dose Moderate cost; convenient liquid form with relatively rapid absorption; alcohol content may be a consideration
Premium formulations $25 – $60 for 30-60 servings $0.85 – $2.00 daily Includes liposomal formulations, water-soluble extracts, and combination products; highest cost but may offer enhanced bioavailability

Value Analysis

Cost Effectiveness Rating: 4 out of 5

Cost Vs Benefit Assessment: Gotu Kola offers good to excellent value for its cognitive enhancement, wound healing, and vascular health benefits. The relatively low cost, especially for basic forms, combined with its well-established safety profile and moderate to strong evidence for several applications, makes it one of the more cost-effective herbal supplements available. For cognitive enhancement, the cost-to-benefit ratio is particularly favorable compared to many synthetic nootropics or premium herbal formulations.

Comparison To Alternatives: For Venous Insufficiency: Significantly less expensive than prescription medications like pentoxifylline or micronized purified flavonoid fraction, with comparable efficacy for mild to moderate cases, For Cognitive Enhancement: Much less expensive than prescription cognitive enhancers, though direct comparative efficacy studies are limited, For Wound Healing: Comparable or lower cost than many advanced wound care products, particularly for minor wounds and prevention of excessive scarring, Vs Ginkgo Biloba: Similar or slightly lower cost for cognitive enhancement, with complementary but different mechanisms of action, Vs Bacopa Monnieri: Comparable cost for cognitive enhancement; Bacopa has more human clinical trials for memory specifically, while Gotu Kola has broader applications, Vs Horse Chestnut: Similar cost range for venous conditions; often used complementarily

Cost Saving Strategies: Purchasing bulk dried herb for tea preparation offers the lowest cost per dose, though standardization and convenience are sacrificed, Buying larger quantities of standardized extracts (e.g., 120-count bottles vs. 60-count) typically reduces cost per dose by 15-30%, Subscription services through online retailers often provide 10-15% discounts for regular purchases, Growing your own Gotu Kola is possible in suitable climates (USDA zones 9-11) and can significantly reduce costs for long-term users

Market Trends

Price Stability: Relatively stable pricing over the past decade with modest inflation-related increases; occasional fluctuations due to harvest conditions in major producing regions

Availability Trends: Increasing availability in Western markets as interest in traditional Ayurvedic and TCM herbs grows

Market Competition: Growing number of manufacturers has helped maintain competitive pricing, particularly for basic forms

Premium Segment Growth: Emerging market for enhanced delivery systems (liposomal, water-soluble) commanding premium prices, targeting the cognitive enhancement and anti-aging markets

Insurance Coverage

Conventional Insurance: Generally not covered by conventional health insurance in most countries

Flexible Spending Accounts: May be eligible for FSA/HSA reimbursement in the US if prescribed by a healthcare provider for a specific medical condition

Integrative Medicine Plans: Some specialized integrative medicine insurance plans or health sharing programs may provide partial coverage

Exceptions: In Germany and some European countries, physician-prescribed herbal medicines may receive partial reimbursement for approved indications

Cost Per Bioactive Compound

Triterpenoid Content: When comparing products, cost per mg of total triterpenoids or specific markers (asiaticoside, madecassoside) provides a more accurate value assessment than simply cost per gram of product

Standardized Extract Value: A 300 mg capsule of extract standardized to 40% triterpenoids provides 120 mg of active compounds, while a 500 mg capsule of raw herb at 2% natural triterpenoid content provides only 10 mg

Calculation Example: For a product costing $20 for 60 capsules of 300 mg standardized to 40% triterpenoids: Cost per mg of triterpenoids = $20 ÷ (60 × 300 mg × 0.40) = $0.0028 per mg of triterpenoids

Long Term Economic Considerations

Preventive Value: Potential cost savings from preventive use for cognitive maintenance and vascular health, though difficult to quantify precisely

Sustainability Concerns: Growing commercial demand has raised concerns about wild harvesting sustainability, which may impact future pricing if cultivation doesn’t keep pace

Research Impact: Ongoing clinical research may increase demand and potentially affect pricing, particularly if new applications receive stronger scientific validation

Stability Information


Shelf Life

Dried Herb: 1-2 years when properly stored in airtight containers away from light, heat, and moisture

Powdered Herb: 6-12 months; more susceptible to oxidation and degradation due to increased surface area

Standardized Extracts: 2-3 years for capsules and tablets; stability enhanced by standardization process and protective packaging

Tinctures: 3-5 years; alcohol content provides preservative effect and extends shelf life

Topical Preparations: 1-2 years unopened; 6-12 months after opening, depending on preservative system and packaging

Storage Recommendations

Temperature: Store between 15-25°C (59-77°F). Avoid temperature extremes; high temperatures accelerate degradation of triterpenoids, while freezing may affect physical stability of liquid preparations.

Humidity: Maintain low humidity environment (<60% relative humidity). Gotu Kola and its extracts can absorb moisture, leading to degradation of active compounds and potential microbial growth.

Light Exposure: Protect from light, especially UV light, which can catalyze oxidation of active compounds. Store in opaque or amber containers.

Air Exposure: Minimize exposure to oxygen, which can oxidize triterpenoids and other active compounds. Use airtight containers and consider oxygen absorbers for bulk storage.

Container Recommendations: Glass or high-density polyethylene (HDPE) containers are preferred for long-term storage. Avoid polyvinyl chloride (PVC) containers, which may interact with plant compounds.

Degradation Factors

Factor Impact Indicators Prevention
Oxidation Primary degradation pathway for triterpenoids, particularly asiatic acid and madecassic acid; results in loss of therapeutic activity Darkening of color, development of rancid odor, reduced potency in analytical testing Antioxidant additives in commercial preparations; nitrogen flushing of packages; airtight containers; oxygen absorbers for bulk storage
Hydrolysis Affects glycosidic bonds in asiaticoside and madecassoside, converting them to their respective aglycones; may alter bioavailability and efficacy Changes in chromatographic profile; shift in ratio of glycosides to aglycones Control of moisture; desiccants in packaging; proper drying before storage
Microbial contamination Can lead to degradation of active compounds, production of toxic metabolites, and safety concerns Visible mold growth, unusual odor, elevated microbial counts in testing Proper drying (moisture content <10%); preservatives in liquid preparations; good manufacturing practices during processing
Enzymatic degradation Plant enzymes can remain active in improperly processed material, leading to degradation of active compounds Rapid loss of potency in freshly dried material; changes in sensory characteristics Heat treatment during processing to inactivate enzymes; proper drying techniques
pH extremes Can accelerate hydrolysis of glycosides and degradation of triterpenoids Particularly relevant for liquid preparations; may show precipitation or color changes pH buffering in liquid formulations; proper formulation design

Stability Testing Methods

Method Description Parameters Monitored Typical Protocol
Accelerated stability testing Storage under elevated temperature and humidity conditions (typically 40°C/75% RH) to predict long-term stability Triterpenoid content, microbial limits, physical appearance, moisture content Testing at 0, 1, 3, and 6 months under accelerated conditions to predict 2-year shelf life under normal conditions
Real-time stability testing Storage under recommended conditions with periodic testing to confirm shelf life estimates Same as accelerated testing, but under actual recommended storage conditions Testing at 0, 3, 6, 12, 18, and 24 months for a 2-year shelf life claim
Photostability testing Exposure to defined light conditions to assess light sensitivity Changes in triterpenoid content, color, and other physical characteristics
Freeze-thaw cycle testing Subjecting product to repeated freezing and thawing to assess physical stability Physical appearance, homogeneity, active compound content

Degradation Products

Primary Degradation Compounds: Oxidation products of asiatic acid and madecassic acid; hydrolysis products of asiaticoside and madecassoside

Safety Implications: Most degradation products have not been associated with significant toxicity, but may result in reduced efficacy

Detection Methods: HPLC with UV or mass spectrometric detection can identify and quantify both parent compounds and degradation products

Formulation Stability Factors

Excipients: Certain excipients can enhance stability, particularly antioxidants (e.g., vitamin E, rosemary extract) for protection against oxidation

Processing Techniques: Microencapsulation, coating, or liposomal formulation can enhance stability by protecting active compounds from environmental factors

Packaging Considerations: Blister packs provide better protection than bottles for solid dosage forms; airless pumps better than jars for creams and gels

Stability Differences By Compound

Asiaticoside And Madecassoside: Generally more stable to oxidation than their aglycones but more susceptible to hydrolysis

Asiatic Acid And Madecassic Acid: More susceptible to oxidation but resistant to hydrolysis; often the first compounds to show degradation in stability testing

Flavonoids And Phenolics: Secondary compounds that contribute to antioxidant activity; generally less stable than triterpenoids and may degrade more rapidly

Reconstitution Guidelines

Dried Extracts: If moisture has caused caking, gentle breaking apart in a dry environment may restore usability; significant clumping or color changes may indicate degradation

Liquid Preparations: If separation occurs, gentle shaking may restore homogeneity; precipitation or significant color changes may indicate degradation and the product should not be used

Travel Considerations

For travel, consider transferring only the needed amount to a small, airtight container rather than exposing the entire supply to variable conditions. Solid dosage forms (tablets, capsules) maintain better stability during travel than liquids or powders. Avoid leaving supplements in hot vehicles or checked luggage that may experience temperature extremes.

Sourcing


Natural Sources

Source Description Active Compound Concentration Sustainability Concerns
Centella asiatica plant Gotu Kola is derived from the Centella asiatica plant, a small herbaceous annual plant native to wetland areas of Asia, particularly India, Sri Lanka, China, Indonesia, and Malaysia. It has also naturalized in parts of Africa, Australia, and the Americas. Wild-harvested plants typically contain 1-8% total triterpenoids, with concentration varying based on growing conditions, harvest time, and plant part used. Increasing commercial demand has led to overharvesting in some regions, raising sustainability concerns. Cultivation is becoming more common to meet demand while preserving wild populations.

Cultivation Methods

Traditional field cultivation
Description: Grown in moist, partially shaded areas with well-draining, fertile soil. Prefers tropical or subtropical climates with consistent moisture.
Yield Information: Yields approximately 1.5-3 tons of fresh herb per hectare, which converts to 300-600 kg of dried herb.
Harvest Timing: Typically harvested 3-6 months after planting, when leaves are fully developed but before flowering for optimal triterpenoid content.
Controlled environment cultivation
Description: Increasingly grown in controlled agricultural environments to standardize growing conditions and maximize active compound content.
Yield Information: Can produce higher yields (up to 4 tons fresh herb per hectare) and more consistent triterpenoid content compared to field cultivation.
Special Considerations: Requires careful control of light, temperature, and humidity; higher production costs but potentially higher quality output.
Organic cultivation
Description: Grown without synthetic pesticides or fertilizers, often using companion planting and natural pest management techniques.
Certification Standards: Various organic certifications including USDA Organic, EU Organic, and others depending on region.
Market Considerations: Commands premium prices; growing consumer demand for certified organic herbal products.
Tissue culture propagation
Description: Laboratory technique used to produce large numbers of genetically identical plants with consistent phytochemical profiles.
Advantages: Allows for selection and propagation of high-triterpenoid cultivars; disease-free starting material; year-round production independent of climate.
Limitations: Higher initial setup costs; requires specialized facilities and expertise.

Processing Methods

Traditional air drying
Description: Freshly harvested plants are cleaned and dried in shaded, well-ventilated areas to preserve active compounds that may degrade with direct sunlight.
Impact On Compounds: Gentle process that preserves most active compounds; some loss of volatile components may occur.
Quality Considerations: Risk of microbial contamination if drying conditions are not properly controlled; slower process but often preferred for traditional preparations.
Controlled temperature drying
Description: Using dehydrators or specialized drying rooms with controlled temperature (typically 30-40°C) and humidity.
Impact On Compounds: Faster drying with minimal degradation of triterpenoids; better preservation of color and appearance.
Quality Considerations: Higher energy costs but more consistent quality; reduced risk of microbial contamination.
Extraction and standardization
Description: Various extraction methods using water, alcohol, or mixed solvents to concentrate active compounds, followed by standardization to specific triterpenoid content.
Common Extraction Solvents: Ethanol (30-70%), methanol, water, or combinations; supercritical CO2 for premium extracts.
Standardization Targets: Typically standardized to total triterpenoid content (40-80%) or specific markers like asiaticoside (10-20%).
Advanced formulation technologies
Description: Techniques to enhance bioavailability and stability of active compounds, including microencapsulation, liposomal delivery, and water-soluble complexation.
Examples: Centell-S (water-soluble extract), liposomal Gotu Kola extracts, phytosome formulations.
Benefits: Improved absorption, targeted delivery, extended shelf life, and potentially enhanced efficacy at lower doses.

Quality Considerations

Identity Verification:

  • Macroscopic and microscopic examination of plant material to confirm correct species
  • DNA barcoding for definitive species identification, particularly important to distinguish from potential adulterants
  • Thin-layer chromatography (TLC) fingerprinting to verify characteristic compound profile
Active Compound Testing:

  • High-Performance Liquid Chromatography (HPLC) for quantification of key triterpenoids (asiaticoside, madecassoside, asiatic acid, madecassic acid)
  • Mass spectrometry for detailed compound identification and quantification
  • Spectrophotometric methods for total triterpenoid content
Contaminant Testing:

  • Heavy metal testing (lead, arsenic, cadmium, mercury) – particularly important as Gotu Kola can accumulate heavy metals from soil
  • Pesticide residue screening – especially relevant for non-organic sources
  • Microbial testing for pathogenic organisms, yeast, and mold
  • Mycotoxin screening, particularly aflatoxins and ochratoxin A
Quality Indicators:

  • Triterpenoid content: Higher-quality products typically contain at least 40% total triterpenoids or 10% asiaticoside
  • Appearance: Properly dried material should maintain a green color; browning indicates poor processing or storage
  • Aroma: Fresh, slightly sweet aroma; musty smell may indicate improper drying or storage
  • Moisture content: Should be below 10% to prevent microbial growth and degradation

Commercial Forms

Dried herb
Description: Whole or cut dried leaves and stems, typically used for teas or traditional preparations.
Typical Potency: 1-8% total triterpenoids, highly variable based on source and processing.
Considerations: Most variable in potency; requires longer preparation time; contains full spectrum of compounds but at lower concentrations.
Powdered herb
Description: Finely ground dried plant material, used in capsules or for direct consumption.
Typical Potency: Similar to dried herb (1-8% triterpenoids) but with improved dissolution due to increased surface area.
Considerations: More convenient than dried herb; still relatively variable in potency; shorter shelf life once ground due to increased oxidation.
Standardized extracts
Description: Concentrated extracts standardized to specific levels of active compounds, typically in capsule or tablet form.
Typical Potency: 40-80% total triterpenoids or 10-20% asiaticoside, depending on standardization method.
Considerations: Most consistent potency; smaller effective dose; may lack some minor compounds present in whole herb; preferred for therapeutic applications.
Tinctures
Description: Alcohol-based liquid extracts, typically in a 1:5 or 1:10 ratio of herb to solvent.
Typical Potency: Variable, but typically equivalent to 200-300 mg dried herb per mL.
Considerations: Rapid absorption; alcohol content may be a concern for some individuals; convenient for flexible dosing.
Topical preparations
Description: Creams, ointments, and gels containing Gotu Kola extract, typically at 1-5% concentration.
Typical Applications: Wound healing, scar prevention, skin conditions, varicose veins.
Considerations: Formulation significantly affects penetration and efficacy; look for products with proven stability and penetration enhancers.
Enhanced delivery systems
Description: Advanced formulations designed to improve bioavailability and efficacy.
Examples: Liposomal extracts, phytosomes, water-soluble complexes (e.g., Centell-S).
Considerations: Higher cost but potentially more effective at lower doses; limited comparative research on enhanced vs. traditional forms.

Reputable Suppliers

Category Examples Quality Indicators
Raw material suppliers
  • Sabinsa Corporation
  • Indena S.p.A.
  • Natural Remedies Pvt. Ltd.
  • Arjuna Natural Extracts Ltd.
  • Sami Labs Limited
GMP certification, standardized extracts, third-party testing, detailed certificates of analysis, sustainable sourcing practices
Consumer supplement brands
  • Himalaya Herbal Healthcare
  • Nature’s Way
  • Gaia Herbs
  • Banyan Botanicals
  • Now Foods
  • Herb Pharm
Standardized extracts, transparent sourcing, third-party testing, clear labeling of active compound content

Storage Recommendations

  • Store in airtight containers away from light, heat, and moisture; shelf life approximately 1-2 years when properly stored.
  • More susceptible to oxidation; store in airtight, opaque containers; shelf life approximately 6-12 months.
  • Generally more stable than raw herb; store according to manufacturer recommendations; typically 2-3 years shelf life for standardized extracts.
  • Store in dark glass bottles away from heat; shelf life approximately 3-5 years due to preservative effect of alcohol.
  • Cool, dry place away from direct sunlight; refrigeration not necessary but may extend shelf life, particularly for liquid preparations after opening.

Historical Usage


Gotu Kola (Centella asiatica) has a rich and extensive history of traditional use spanning thousands of years across multiple medical systems, particularly in Asia. In Ayurvedic medicine, where it is known as ‘Brahmi’ or ‘Mandukaparni,’ Gotu Kola has been used for at least 3,000 years and is mentioned in ancient texts including the Sushruta Samhita (circa 6th century BCE). Ayurvedic practitioners classified it as a ‘medhya rasayana,’ an herb that enhances memory and longevity, and used it to treat a wide range of conditions including skin disorders, nervous system ailments, and to promote mental clarity and spiritual development. It was considered one of the primary herbs for balancing the pitta dosha (fire element) and was believed to enhance all three doshas (vata, pitta, and kapha).

In Traditional Chinese Medicine (TCM), where it is known as ‘Ji Xue Cao’ (literally ‘gathering blood herb’), Gotu Kola has been used for over 2,000 years. Chinese physicians primarily employed it to clear heat, promote diuresis, detoxify the body, and heal wounds. It was particularly valued for treating fevers, urinary tract infections, and skin conditions including leprosy. TCM practitioners also recognized its cooling properties and used it to balance excess heat in the liver and to promote longevity.

In traditional Indonesian medicine, Gotu Kola (known locally as ‘Pegagan’) has been used for centuries to enhance memory, treat fever, improve circulation, and heal wounds. Indonesian mothers traditionally gave Gotu Kola to children to enhance their intelligence and mental development. In Sri Lankan traditional medicine (Sinhala medicine), the herb (known as ‘Gotukola’) has been a staple in the diet and medical system for generations, used both as a medicinal herb and a common leafy vegetable. Sri Lankan practitioners used it to purify blood, promote wound healing, and improve mental function.

Throughout Southeast Asia, Gotu Kola gained a reputation as a longevity herb, with legends of ancient sages living for extraordinary lengths of time by consuming it regularly. This led to its nickname ‘the herb of longevity’ or ‘fountain of youth.’ The herb’s association with the elephant’s memory and longevity (elephants are known to eat the plant in the wild) further cemented its reputation for enhancing cognitive function and extending lifespan. In folk medicine across various cultures, Gotu Kola was commonly applied topically as a poultice for wounds, burns, and skin conditions. It was also prepared as teas, decoctions, and fresh juices for internal use.

Traditional preparation methods varied by region but often involved either consuming the fresh leaves, creating dried powders, or extracting the herb in water, milk, ghee (clarified butter), or alcohol. The introduction of Gotu Kola to Western medicine began in the early 20th century when European researchers began investigating its wound-healing properties. French scientists in the 1930s and 1940s conducted some of the first modern research on the herb, particularly for treating leprosy and skin conditions. By the mid-20th century, standardized extracts of Centella asiatica, particularly the total triterpenoid fraction (TTFCA), began to be used in European clinical settings for wound healing and vascular conditions.

The herb gained significant attention in Western herbal medicine during the 1960s and 1970s as interest in traditional medical systems increased. Modern scientific research began to validate many of its traditional uses, particularly for wound healing, venous insufficiency, and cognitive enhancement. Today, Gotu Kola continues to be used in its traditional contexts while also being incorporated into modern integrative medicine practices worldwide. It has transitioned from primarily traditional use to becoming a well-researched herbal medicine with applications supported by both centuries of empirical observation and modern scientific investigation.

The herb represents a fascinating example of traditional wisdom that has withstood the test of time and continues to find relevance in contemporary healthcare approaches.

Scientific Evidence


Evidence Rating i

3Evidence Rating: Moderate Evidence – Multiple studies with generally consistent results

Evidence Summary

Gotu Kola (Centella asiatica) has a moderate to strong body of scientific evidence supporting several of its traditional uses, particularly for wound healing, venous insufficiency, and cognitive function. The research includes numerous in vitro and animal studies, as well as a growing number of human clinical trials, though many are of moderate quality or have methodological limitations. The strongest evidence exists for its wound healing and venous applications, with emerging but promising evidence for its cognitive and neuroprotective effects.

The active triterpenoid compounds have been well-characterized, and their mechanisms of action are increasingly understood at the molecular level.

Key Studies

Study Title: Centella asiatica Extract Improves Behavioral Deficits in a Mouse Model of Alzheimer’s Disease: Investigation of a Possible Mechanism of Action
Authors: Soumyanath A., Zhong Y.P., Henson E., Wadsworth T., Bishop J., Gold B.G., Quinn J.F.
Publication: International Journal of Alzheimer’s Disease
Year: 2012
Doi: 10.1155/2012/381974
Url: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272127/
Study Type: Animal study
Population: Transgenic mouse model of Alzheimer’s disease (Tg2576)
Findings: Gotu Kola extract (100 mg/kg/day for 2 weeks) improved cognitive performance in the Morris water maze test and reduced amyloid beta pathology in the brains of Alzheimer’s model mice. The extract increased phosphorylation of cyclic AMP response element binding protein (CREB) in hippocampal neurons, a mechanism associated with memory formation.
Limitations: Animal model; relatively short treatment duration; needs confirmation in human studies

Study Title: Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A Systematic Review and Meta-analysis
Authors: Puttarak P., Dilokthornsakul P., Saokaew S., Dhippayom T., Kongkaew C., Sruamsiri R., Chuthaputti A., Chaiyakunapruk N.
Publication: Scientific Reports
Year: 2017
Doi: 10.1038/s41598-017-09823-9
Url: https://www.nature.com/articles/s41598-017-09823-9
Study Type: Systematic review and meta-analysis
Population: 9 randomized controlled trials with 579 participants
Findings: Meta-analysis showed significant improvements in cognitive function domains including overall cognition, attention, and executive function with Gotu Kola supplementation compared to placebo. Mood improvements were also noted in several studies.
Limitations: Heterogeneity in study designs, dosages, and outcome measures; some included studies had small sample sizes

Study Title: Efficacy of a standardized extract of Centella asiatica (ECa 233) for anxiety treatment: A randomized, double-blind, placebo-controlled trial
Authors: Wattanathorn J., Mator L., Muchimapura S., Tongun T., Pasuriwong O., Piyawatkul N., Yimtae K., Sripanidkulchai B., Singkhoraard J.
Publication: Journal of Ethnopharmacology
Year: 2008
Doi: 10.1016/j.jep.2007.12.011
Url: https://www.sciencedirect.com/science/article/abs/pii/S0378874107006678
Study Type: Randomized controlled trial
Population: 40 healthy elderly volunteers with mild cognitive impairment
Findings: Participants receiving 750 mg of standardized Gotu Kola extract daily for 2 months showed significant improvements in working memory and decreased anxiety compared to placebo. The extract was well-tolerated with no serious adverse effects.
Limitations: Relatively small sample size; short duration; limited to elderly population

Study Title: Randomized, placebo-controlled, double-blind clinical trial of Centella asiatica on cognitive function in healthy elderly volunteers
Authors: Dev R.D.O., Mohamed S., Hambali Z., Samah B.A.
Publication: Evidence-Based Complementary and Alternative Medicine
Year: 2009
Doi: 10.1093/ecam/nep063
Url: https://www.hindawi.com/journals/ecam/2009/465845/
Study Type: Randomized controlled trial
Population: 28 healthy elderly volunteers
Findings: Participants receiving 500 mg of Gotu Kola extract twice daily for 6 weeks showed significant improvements in several cognitive domains, including attention, concentration, and memory, compared to placebo. The extract was well-tolerated.
Limitations: Small sample size; relatively short duration; limited generalizability to other populations

Study Title: Efficacy of Centella asiatica in Improving the Healing of Venous Ulcers: A Randomized, Double-Blind, Placebo-controlled Study
Authors: Incandela L., Belcaro G., Cesarone M.R., De Sanctis M.T., Nargi E., Patricelli P., Bucci M.
Publication: Angiology
Year: 2001
Doi: 10.1177/000331970105200S15
Url: https://journals.sagepub.com/doi/10.1177/000331970105200S15
Study Type: Randomized controlled trial
Population: 94 patients with venous hypertension and ulceration
Findings: Treatment with total triterpenic fraction of Centella asiatica (TTFCA) at 60 mg twice daily for 8 weeks significantly improved venous ulcer healing rates, reduced ulcer size, and improved microcirculation compared to placebo. The treatment was well-tolerated.
Limitations: Focused on a specific extract (TTFCA); may not generalize to all Gotu Kola preparations

Study Title: Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin-induced cardiomyopathy in rats
Authors: Gnanapragasam A., Ebenezar K.K., Sathish V., Govindaraju P., Devaki T.
Publication: Life Sciences
Year: 2004
Doi: 10.1016/j.lfs.2003.09.062
Url: https://www.sciencedirect.com/science/article/abs/pii/S0024320503010466
Study Type: Animal study
Population: Rats with adriamycin-induced cardiomyopathy
Findings: Pretreatment with Gotu Kola extract (200 mg/kg/day) significantly protected against adriamycin-induced cardiotoxicity by enhancing antioxidant defense systems, reducing lipid peroxidation, and preserving cardiac function.
Limitations: Animal model; preventive rather than therapeutic protocol; needs confirmation in human studies

Meta Analyses

Title: Efficacy of Centella asiatica in Cognitive and Mood Outcomes in Healthy Older People: A Systematic Review and Meta-analysis
Authors: Puttarak P., Dilokthornsakul P., Saokaew S., Dhippayom T., Kongkaew C., Sruamsiri R., Chuthaputti A., Chaiyakunapruk N.
Publication: Scientific Reports
Year: 2017
Doi: 10.1038/s41598-017-09823-9
Key Findings: Meta-analysis of 9 randomized controlled trials showed significant improvements in overall cognition (standardized mean difference [SMD] = 0.48; 95% CI 0.15-0.81), attention (SMD = 0.37; 95% CI 0.06-0.68), and executive function (SMD = 0.32; 95% CI 0.01-0.63) with Gotu Kola supplementation compared to placebo.

Title: Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential
Authors: Lokanathan Y., Omar N., Ahmad Puzi N.N., Saim A., Hj Idrus R.
Publication: Evidence-Based Complementary and Alternative Medicine
Year: 2016
Doi: 10.1155/2016/9634750
Key Findings: Comprehensive review of preclinical and clinical evidence supporting Gotu Kola’s neuroprotective effects, including mechanisms related to antioxidant activity, mitochondrial protection, anti-inflammatory effects, and inhibition of acetylcholinesterase. The review highlighted consistent evidence across multiple models of neurological disorders.

Ongoing Trials

Title: Effects of Centella asiatica on Cognitive Function in Mild Cognitive Impairment
Institution: Oregon Health & Science University
Status: Completed, results pending
Estimated Completion: 2023
Registration: NCT03937908
Design: Randomized, double-blind, placebo-controlled trial with 80 participants with mild cognitive impairment

Title: Evaluation of Centella asiatica Extract in Anxiety Disorders: A Randomized Controlled Trial
Institution: Chiang Mai University, Thailand
Status: Recruiting
Estimated Completion: 2024
Registration: TCTR20210615001
Design: Randomized, double-blind, placebo-controlled trial with 120 participants with generalized anxiety disorder

Research Gaps

Long-term safety and efficacy studies (>12 months) are lacking, Limited research on potential interactions with commonly prescribed medications, Insufficient standardization across studies regarding extract composition and dosing, Need for larger, well-designed clinical trials in diverse populations, Limited research on comparative efficacy versus conventional treatments for specific conditions, Incomplete understanding of the relative contributions of individual compounds to the overall therapeutic effects

Expert Consensus

There is growing consensus among researchers and clinicians that Gotu Kola has legitimate therapeutic potential, particularly for cognitive enhancement, wound healing, and venous conditions. The herb is generally recognized as safe

when used appropriately, though experts emphasize the importance of using standardized extracts for therapeutic purposes.

While traditional uses span a wide range of conditions, experts typically focus on the applications with stronger scientific support.

There is particular interest in its potential as a neuroprotective agent for age-related cognitive decline and neurodegenerative conditions, though most experts agree that larger clinical trials are needed before making definitive recommendations for

these applications.

Historical Research Trends

Research on Gotu Kola has evolved significantly over the past several decades. Early studies (1970s-1990s) focused primarily on its wound healing and dermatological applications, with particular attention to its effects on collagen synthesis and fibroblast proliferation. The late 1990s and early 2000s saw increased interest in its vascular effects, particularly for chronic venous insufficiency and microangiopathy. Since the 2010s, there has been a notable shift toward investigating its neurological and cognitive effects, reflecting growing interest in natural approaches to cognitive enhancement and neuroprotection.

Recent research has increasingly focused on elucidating molecular mechanisms and identifying specific active compounds responsible for various therapeutic effects, with particular attention to the triterpenoid constituents.

Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a healthcare professional before starting any supplement regimen, especially if you have pre-existing health conditions or are taking medications.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top